Magazine Article | September 1, 2022

The Case For Implementing TransCelerate's Modernization Of Statistical Analysis Framework

Source: Life Science Leader

By Lin Taft

As the life sciences industry modernizes across all aspects of the field — from electronic health record data to consumer wearables — it is crucial that statistical analytics of clinical trial data for delivering drugs efficiently and safely to patients keeps pace and steps into the modern era as well.

This is especially important now for the pharma industry to expand on the options of analytical tools. In this highly regulated field, it is critical to ensure that all these tools being used to analyze data as part of clinical trial evidence-gathering efforts can be relied upon to produce accurate and consistent results capable of supporting regulatory submissions.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader